Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F M Platt

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Expert Reviews in Molecular Medicine|October 31, 2003
Substrate deprivation: a new therapeutic approach for the glycosphingolipid lysosomal storage diseasesF M Platt, T D Butters
Expert Opinion on Investigational Drugs|February 28, 2001
Substrate reduction therapy for glycosphingolipid storage disordersR H Lachmann, F M Platt
Analytical Biochemistry|December 1, 1991
Analysis and isolation of human transferrin receptor using the OKT-9 monoclonal antibody covalently crosslinked to magnetic beadsG B Karlsson, F M Platt
Biochemical Pharmacology|October 8, 1998
New therapeutic prospects for the glycosphingolipid lysosomal storage diseasesF M Platt, T D Butters
European Journal of Biochemistry|August 15, 1992
Modulation of cell-surface transferrin receptor by the imino sugar N-butyldeoxynojirimycinF M Platt, G B Karlsson, G S Jacob
Advances in Experimental Medicine and Biology|January 13, 2004
New therapeutics for the treatment of glycosphingolipid lysosomal storage diseasesT D Butters, R A Dwek, F M Platt
Chemical Reviews|December 26, 2001
Inhibition of glycosphingolipid biosynthesis: application to lysosomal storage disordersT D Butters, R A Dwek, F M Platt
Journal of Neurochemistry|February 7, 1998
Inhibition of glycosphingolipid biosynthesis does not impair growth or morphogenesis of the postimplantation mouse embryoJ V Brigande, F M Platt, T N Seyfried
Neuropathology and Applied Neurobiology|October 9, 2002
Glycosphingolipid lysosomal storage diseases: therapy and pathogenesisM Jeyakumar, T D Butters, R A Dwek, et al.
The Journal of Biological Chemistry|August 1, 1997
Extensive glycosphingolipid depletion in the liver and lymphoid organs of mice treated with N-butyldeoxynojirimycinF M Platt, G Reinkensmeier, R A Dwek, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Expert Reviews in Molecular Medicine|October 31, 2003
Substrate deprivation: a new therapeutic approach for the glycosphingolipid lysosomal storage diseasesF M Platt, T D Butters
Expert Opinion on Investigational Drugs|February 28, 2001
Substrate reduction therapy for glycosphingolipid storage disordersR H Lachmann, F M Platt
Analytical Biochemistry|December 1, 1991
Analysis and isolation of human transferrin receptor using the OKT-9 monoclonal antibody covalently crosslinked to magnetic beadsG B Karlsson, F M Platt
Biochemical Pharmacology|October 8, 1998
New therapeutic prospects for the glycosphingolipid lysosomal storage diseasesF M Platt, T D Butters
European Journal of Biochemistry|August 15, 1992
Modulation of cell-surface transferrin receptor by the imino sugar N-butyldeoxynojirimycinF M Platt, G B Karlsson, G S Jacob
Advances in Experimental Medicine and Biology|January 13, 2004
New therapeutics for the treatment of glycosphingolipid lysosomal storage diseasesT D Butters, R A Dwek, F M Platt
Chemical Reviews|December 26, 2001
Inhibition of glycosphingolipid biosynthesis: application to lysosomal storage disordersT D Butters, R A Dwek, F M Platt
Journal of Neurochemistry|February 7, 1998
Inhibition of glycosphingolipid biosynthesis does not impair growth or morphogenesis of the postimplantation mouse embryoJ V Brigande, F M Platt, T N Seyfried
Neuropathology and Applied Neurobiology|October 9, 2002
Glycosphingolipid lysosomal storage diseases: therapy and pathogenesisM Jeyakumar, T D Butters, R A Dwek, et al.
The Journal of Biological Chemistry|August 1, 1997
Extensive glycosphingolipid depletion in the liver and lymphoid organs of mice treated with N-butyldeoxynojirimycinF M Platt, G Reinkensmeier, R A Dwek, et al.
Pageof 5